or Try an Advanced Search...

    Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 21.34 0.95% 0.20
    LBPH closed up 3.88 percent on Wednesday, May 15, 2024, on 44 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical LBPH trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.95%
    Gapped Up Strength 0.95%
    50 DMA Support Bullish 4.86%
    Crossed Above 20 DMA Bullish 4.86%
    Doji - Bullish? Reversal 4.86%
    Multiple of Ten Bullish Other 4.86%
    Outside Day Range Expansion 4.86%
    Wide Bands Range Expansion 4.86%
    Gapped Up Strength 4.86%
    Fell Below 20 DMA Bearish 7.07%
    Older End-of-Day Signals for LBPH ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 10 DMA 3 minutes ago
    Up 5% about 22 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    Rose Above 10 DMA about 22 hours ago
    Gap Up Partially Closed about 24 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    LBPH Chart by TradingView
    Basic chart:

    Profile

    Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Amyotrophic Lateral Sclerosis Neurophysiology Neurology Nervous System Clinical Trial Product Neurological Diseases

    Is LBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans
    May 4 Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
    May 3 Longboard Pharmaceuticals EPS of -$0.42 beats by $0.07
    May 2 Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    May 1 Starbucks downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
    Apr 3 Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
    Mar 27 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50%
    Mar 16 Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely
    Mar 14 Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results
    Mar 12 Recap: Longboard Pharmaceuticals Q4 Earnings
    See more LBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 28.15
    52 Week Low 3.6
    Average Volume 424,043
    200-Day Moving Average 12.81
    50-Day Moving Average 19.89
    20-Day Moving Average 20.48
    10-Day Moving Average 21.21
    Average True Range 1.39
    RSI (14) 53.49
    ADX 16.38
    +DI 24.06
    -DI 18.39
    Chandelier Exit (Long, 3 ATRs) 19.79
    Chandelier Exit (Short, 3 ATRs) 20.71
    Upper Bollinger Bands 23.24
    Lower Bollinger Band 17.72
    Percent B (%b) 0.62
    BandWidth 26.94
    MACD Line 0.35
    MACD Signal Line 0.41
    MACD Histogram -0.0536
    Fundamentals Value
    Market Cap 696.28 Million
    Num Shares 32.9 Million
    EPS -2.43
    Price-to-Earnings (P/E) Ratio -8.70
    Price-to-Sales 0.00
    Price-to-Book 13.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 22.69
    Resistance 3 (R3) 22.60 22.01 22.43
    Resistance 2 (R2) 22.01 21.61 22.05 22.34
    Resistance 1 (R1) 21.57 21.37 21.79 21.66 22.26
    Pivot Point 20.98 20.98 21.09 21.02 20.98
    Support 1 (S1) 20.54 20.58 20.76 20.63 20.02
    Support 2 (S2) 19.95 20.34 19.99 19.94
    Support 3 (S3) 19.51 19.95 19.85
    Support 4 (S4) 19.60